Overview

Control of Major Bleeding After Trauma Study

Status:
Terminated
Trial end date:
2017-04-03
Target enrollment:
Participant gender:
Summary
Bleeding is the most avoidable cause of death in trauma patients. Up to one-third of severely injured trauma patients are found to be coagulopathic and forty percent of the mortality following severe injury is due to uncontrollable hemorrhage in the setting of coagulopathy. It has been established that early administration of fresh frozen plasma decreases mortality following severe injury, replacing lost coagulation factors, improving the coagulopathy and restoring blood volume. This study will determine if giving plasma to severely injured trauma patients during ambulance transport versus after arrival to the hospital will help reduce hemorrhage, thus decreasing both total blood product administration and mortality.
Phase:
Phase 2
Details
Lead Sponsor:
Denver Health and Hospital Authority
Collaborators:
U.S. Army Medical Research and Development Command
U.S. Army Medical Research and Materiel Command
University of Colorado, Denver